News & Updates

Abbreviated vs prolonged DAPT: Is shorter better for at-risk patients?

19 Jun 2025

One-month treatment with dual antiplatelet therapy (DAPT) results in similar adverse events and a reduction in total bleeding risk when compared with prolonged DAPT, a study has shown.

Abbreviated vs prolonged DAPT: Is shorter better for at-risk patients?

19 Jun 2025

Study ties energy drink intake to unhealthy lifestyle in young individuals

19 Jun 2025 by

A study presented at ESPGHAN 2025 reports that schoolchildren who consume energy drinks have unhealthier lifestyles and a different cardiovascular risk profile than their counterparts who do not or rarely consume energy drinks.

Study ties energy drink intake to unhealthy lifestyle in young individuals

19 Jun 2025

Inclisiran superior to ezetimibe in LDL-C reduction in patients without ASCVD

18 Jun 2025

Treatment with inclisiran monotherapy demonstrates good tolerability and better reduction in low-density lipoprotein cholesterol (LDL-C) levels when compared with ezetimibe and placebo in patients without atherosclerotic cardiovascular disease (ASCVD), reports a study.

Inclisiran superior to ezetimibe in LDL-C reduction in patients without ASCVD

18 Jun 2025

Ferric carboxymaltose infusion offers little help in iron-deficient patients with heart failure

17 Jun 2025

Intravenous ferric carboxymaltose does not appear to be beneficial in terms of heart failure (HF) hospitalization and cardiovascular mortality in patients with HF and iron deficiency, according to a study.

Ferric carboxymaltose infusion offers little help in iron-deficient patients with heart failure

17 Jun 2025

SGLT2i extends survival in amyloidosis patients with or without HF

16 Jun 2025 by

Treatment with SGLT2 inhibitors can prolong the life of patients with amyloidosis with or without a diagnosis of heart failure (HF), a study has shown.

SGLT2i extends survival in amyloidosis patients with or without HF

16 Jun 2025

Phone-based strategy supports BP control after a stroke

13 Jun 2025 by

A nurse-led mobile health (mHealth) intervention that utilizes basic phones improves blood pressure (BP) control among stroke survivors in Ghana, as shown in the phase III PINGS-2 trial.

Phone-based strategy supports BP control after a stroke

13 Jun 2025

Wearables fare well for AF detection

13 Jun 2025 by

A systematic review and meta-analysis of 15 studies attest to the efficacy of single-lead electrocardiogram (ECG) smart chest patches and photoplethysmography (PPG)-based smartwatches for atrial fibrillation (AF) detection.

Wearables fare well for AF detection

13 Jun 2025

VTE event risk up in PD patients

12 Jun 2025 by

Researchers from Singapore found an elevated risk of venous thromboembolism (VTE) events in individuals with Parkinson’s disease (PD) in a systematic review and meta-analysis of 13 studies.

VTE event risk up in PD patients

12 Jun 2025

Protecting the vulnerable: The role of oral antivirals in COVID-19 management

12 Jun 2025

At the Asia Vaccines and Antivirals Summit (AVAS) 2025 held in Bangkok, Thailand, two expert-led sessions provided valuable perspectives on the expanding role of oral antivirals in COVID-19 management. Dr Daniel Griffin, an infectious disease specialist and Clinical Instructor of Medicine at Columbia University, New York, US, focused on protecting high-risk populations through the timely use of antiviral therapy. Complementing this, Professor Ching-Tai Huang of Chang Gung University and Memorial Hospital in Taiwan offered practical guidance on clinical management strategies, including patient risk stratification and therapeutic selection.

Protecting the vulnerable: The role of oral antivirals in COVID-19 management

12 Jun 2025

TRICH score predicts triple antihypertensive therapy need after ICH

10 Jun 2025 by

A team from the LKS Faculty of Medicine at the University of Hong Kong (HKU) has developed an innovative clinical tool to help physicians effectively identify intracerebral haemorrhage (ICH) patients who would benefit from early initiation of triple antihypertensive therapy to reduce the risks of ICH recurrence and subsequent strokes.

TRICH score predicts triple antihypertensive therapy need after ICH

10 Jun 2025

News & Updates

Filter by Specialty:

Specialty:

Abbreviated vs prolonged DAPT: Is shorter better for at-risk patients?

Abbreviated vs prolonged DAPT: Is shorter better for at-risk patients?

Study ties energy drink intake to unhealthy lifestyle in young individuals

Study ties energy drink intake to unhealthy lifestyle in young individuals

Inclisiran superior to ezetimibe in LDL-C reduction in patients without ASCVD

Inclisiran superior to ezetimibe in LDL-C reduction in patients without ASCVD

Ferric carboxymaltose infusion offers little help in iron-deficient patients with heart failure

Ferric carboxymaltose infusion offers little help in iron-deficient patients with heart failure

SGLT2i extends survival in amyloidosis patients with or without HF

SGLT2i extends survival in amyloidosis patients with or without HF

Phone-based strategy supports BP control after a stroke

Phone-based strategy supports BP control after a stroke

Wearables fare well for AF detection

Wearables fare well for AF detection

VTE event risk up in PD patients

VTE event risk up in PD patients

Protecting the vulnerable: The role of oral antivirals in COVID-19 management

Protecting the vulnerable: The role of oral antivirals in COVID-19 management

TRICH score predicts triple antihypertensive therapy need after ICH

TRICH score predicts triple antihypertensive therapy need after ICH